Genome-wide interrogation of structural variation reveals novel African-specific prostate cancer oncogenic drivers
Abstract
African ancestry is a significant risk factor for advanced prostate cancer (PCa). Mortality rates in sub-Saharan Africa are 2.5-fold greater than global averages. However, the region has largely been excluded from the benefits of whole genome interrogation studies. Additionally, while structural variation (SV) is highly prevalent, PCa genomic studies are still biased towards small variant interrogation.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Aug 31, 2022
- Source ID
- 10.1186/s13073-022-01096-w
Entities
People
- Anne-maree Haynes
- Anthony T. Papenfuss
- Cali Willet
- Eva K. F. Chan
- Gabriela Pasqualim
- Ilma Simoni Brum
- Jue Jiang
- Phillip D. Stricker
- Riana M. S. Bornman
- Rosemarie Sadsad
- Ruth J. Lyons
- Sean M. Patrick
- Shingai B. A. Mutambirwa
- Tingting Gong
- Tracy Chew
- Vanessa Hayes
- Weerachai Jaratlerdsiri
Organizations
- National Health and Medical Research Council
- University of Sydney